High level of NRP1 in lung cancer tissues is associated with poor survival, making it a potential therapeutic target in COVID-19 patients with lung cancer, while high level of TMPRSS2 correlates with better prognosis, excluding the attempt of targeting TMPRSS2 in comorbidity. Here, NRP1 is linked to lung cancer.